GlassScriptPhysician profile
Jacques R Conaway
NPI 1437245362
$5,375.89
in general payments reported to CMS, 2019-2025
41 companies · $692 in 2025
The $692 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $680 · 2020: $503 · 2021: $366 · 2022: $2,253 · 2023: $278 · 2024: $604 · 2025: $692.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,574.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,573.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $1,895.22 | 2021-2024 | Inspire |
| Glaxosmithkline, LLC. | $871.96 | 2019-2025 | Trelegy Ellipta, Arexvy, Nucala |
| Astrazeneca Pharmaceuticals LP | $434.80 | 2019-2025 | Breztri, Airsupra, Fasenra |
| Harmony Biosciences LLC | $241.17 | 2020-2023 | Wakix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $130.56 | 2019-2025 | Jardiance |
| Eisai INC. | $125.00 | 2020 | |
| Jazz Pharmaceuticals INC. | $113.26 | 2019-2025 | |
| Baxter Healthcare | $108.19 | 2022-2024 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Livanova USA, INC. | $103.37 | 2025 | Thn Sleep Therapy |
| Regeneron Healthcare Solutions, INC. | $96.72 | 2019-2025 | Dupixent |
| Novartis Pharmaceuticals Corporation | $90.49 | 2022-2023 | |
| Sunovion Pharmaceuticals INC. | $89.57 | 2019-2020 | |
| Mylan Specialty L.P. | $80.84 | 2019-2020 | |
| Idorsia Pharmaceuticals US INC | $78.17 | 2022 | |
| Viatris Specialty LLC | $69.61 | 2025 | Yupelri |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $66.79 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| 3b Medical, INC. | $62.15 | 2025 | Luna |
| Alexion Pharmaceuticals, INC. | $61.60 | 2019-2025 | Strensiq |
| Boston Scientific Corporation | $60.79 | 2023-2025 | Ekosonic, General - Dbs, Angiojet Ultra 5000a |
| Grifols USA, LLC | $60.14 | 2019 | |
| Verona Pharma, INC. | $56.78 | 2025 | Ohtuvayre |
| Lilly USA, LLC | $52.74 | 2024-2025 | Mounjaro, Zepbound |
| Insulet Corporation | $36.80 | 2021 | |
| Novo Nordisk INC | $33.85 | 2024 | Ozempic, Rybelsus |
| Janssen Pharmaceuticals, INC | $32.03 | 2019-2020 | |
| Pfizer INC. | $31.79 | 2021 | |
| Advanced Respiratory, INC | $29.17 | 2019 | |
| Sumitomo Pharma America, INC. | $25.90 | 2025 | Gemtesa |
| Amarin Pharma, INC. | $23.73 | 2021 | |
| Gilead Sciences, INC. | $23.32 | 2021 | |
| Genentech USA, INC. | $21.27 | 2019 | |
| Corcept Therapeutics | $20.45 | 2022 | |
| Axsome Therapeutics, INC. | $20.29 | 2025 | Sunosi |
| Sanofi-Aventis U.S. LLC | $18.54 | 2024 | |
| Amgen INC. | $17.00 | 2021 | |
| Vifor Pharma, INC. | $16.20 | 2025 | Zemaira |
| Philips North America LLC | $16.06 | 2020 | |
| Genzyme Corporation | $15.74 | 2020 | |
| Neurelis, INC. | $14.89 | 2023 | Valtoco |
| Resmed Corp | $14.56 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $14.38 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacques Conaway listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.